| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5734598 | Surgery | 2017 | 11 Pages |
Abstract
When selecting patients for portal vein embolization, future remnant liver function assessed with hepatobiliary scintigraphy can be used as a predictor of insufficient functional hypertrophy after portal vein embolization, especially in nonchemotherapy patients. These patients are potential candidates for ALPPS.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Kasia P. MD, Floor MD, Thomas BSc, Roelof J. MD, PhD, Krijn P. MD, PhD, Joanne MD, PhD, Marc G. MD, PhD, Olivier R.C. MD, PhD, Thomas M. MD, PhD,